TP53 and colorectal carcinoma: Moreover, recent evidence shows that miR-25-3p may also act with LncRNAs on a LINC00858/miR-25/SMAD7 axis modulating TP53-wild expression in colorectal carcinoma (Zhan et al., 2020).